atiii
antithrombin iii
study
patients
azienda ospedaliera careggi
congenital atiii deficiency
sepsis
italian hospitals
atiii deficiency
iii
congenital atiii
italian
antithrombin
observational
care
drug
observational study
clinical
randomized
ospedaliera careggi